Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Verona Pharma PLC
Capital Expenditures Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Capital Expenditures
-$45k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Capital Expenditures
-ÂŁ2.3B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
AstraZeneca PLC
LSE:AZN
Capital Expenditures
-$4.1B
CAGR 3-Years
-25%
CAGR 5-Years
-11%
CAGR 10-Years
-3%
Indivior PLC
LSE:INDV
Capital Expenditures
-$52m
CAGR 3-Years
-14%
CAGR 5-Years
-24%
CAGR 10-Years
-6%
Hikma Pharmaceuticals PLC
LSE:HIK
Capital Expenditures
-$205m
CAGR 3-Years
2%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Dechra Pharmaceuticals PLC
LSE:DPH
Capital Expenditures
-ÂŁ30.3m
CAGR 3-Years
15%
CAGR 5-Years
-19%
CAGR 10-Years
-13%

See Also

What is Verona Pharma PLC's Capital Expenditures?
Capital Expenditures
-45k USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Capital Expenditures amounts to -45k USD.

Back to Top